MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-09-0006158
DSS Takara Bio India Private Limited - life sciences in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹39.54 Cr
▼ 37% YoY
Net profit · FY 2023
₹3.38 Cr
Net margin 8.6%
EBITDA · FY 2023
₹3.77 Cr
EBITDA margin 9.5%
Authorised capital
₹11 Cr
Registered with MCA
Paid-up capital
₹11 Cr
Issued & subscribed
Company age
15 yrs
Est. 2011
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered
About DSS Takara Bio India Private Limited
Data last updated:
DSS Takara Bio India Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Takara Bio Inc. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 03 May 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2011PTC218463. Its GSTIN is 07AADCD8286B1ZO (Delhi).
The company has an authorised share capital of ₹11 Cr and a paid-up capital of ₹11 Cr. It is led by directors including Arvinder Singh Dhingra (Managing Director) and Haruhisa Sawaragi.
Its last annual general meeting (AGM) was held on 27 May 2025, and its latest financial statements are for the year ended 31 December 2024. The registered office is at A – 5 Mohan Cooperative Industrial Estate Mathura Road Opp. Sarita Vihar, New Delhi, Delhi, India – 110044.
As per the financials filed for FY 2023, the company reported a revenue of ₹39.54 Cr, a decline of 37% compared to the previous year. For the same year it recorded a net profit of ₹3.38 Cr (net margin 8.6%) and EBITDA of ₹3.77 Cr (EBITDA margin 9.5%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 14% over five years.
The company is associated with 1 brand: DSS Takara Bio. Court records list 5 cases involving the company, including 5 filed by the company. The company has 2 deals on record (2 funding rounds), with disclosed funding of ₹10.95 Cr; the latest was in April 2013. Its 4 peer companies in the Biotechnology industry (Biotechnology), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 2 smaller; the largest is Bharat Immunologicals and Biologicals Corporation Limited with revenue of ₹79.49 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2020, listing 1 overdue payment to 1 micro and small supplier.
DSS Takara Bio India Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-09-0006158). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website takarabio.com.
Company details
CIN U24232DL2011PTC218463
Registration Number 218463
Incorporation Date 03 May 2011
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 May 2025
Date of Balance Sheet 31 December 2024
Parent Company Takara Bio Inc
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-09-0006158
Key People
Arvinder Singh Dhingra Managing Director Haruhisa Sawaragi Nominee Director Hiroki Tomohisa Nominee Director Recognitions & Rankings of DSS Takara Bio India
Contact details
DSS Takara Bio India Private Limited's registered office is in New Delhi, Delhi. Its website is takarabio.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressA – 5 Mohan Cooperative Industrial Estate Mathura Road Opp. Sarita Vihar, New Delhi, Delhi, India – 110044
- IndustryLife Sciences, Biotechnology
To see the full contact details of DSS Takara Bio India Private Limited, buy the company report.
Comprehensive company report
DSS Takara Bio India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
DSS Takara Bio India operates one associated brand: DSS Takara Bio. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Delivers comprehensive molecular biology kits and reagents. | dsstakarabio.com |
Financials of DSS Takara Bio India Private Limited
FY 2024 filings availableDSS Takara Bio India Private Limited reported revenue of ₹39.54 Cr (down 37% YoY) for FY 2023.
Revenue · FY 2023
₹39.54 Cr ▼ 37%
Net profit · FY 2023
₹3.38 Cr margin 8.6%
EBITDA · FY 2023
₹3.77 Cr margin 9.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 37%
3 years · compounded
▼ 5%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▼ 29%
3 years · compounded
▼ 17%
5 years · compounded
▲ 36%
Revenue fell 37% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 14%. EBITDA fell 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹39.54 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.77 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.38 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.5% | ||||
| Net Profit Margin | 8.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of DSS Takara Bio India Private Limited, buy the company report.
Board of directors of DSS Takara Bio India Private Limited
DSS Takara Bio India has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Haruhisa Sawaragi | Nominee Director | 26 Jun 2014 | 12 Years 4 Months | Current |
| Hiroki Tomohisa | Nominee Director | 27 May 2025 | 1 Years 5 Months | Current |
| Arvinder Singh Dhingra Also directs: Neodx Biotech Labs Private Limited, Magnus Opto Systems India Private Limited, DSS Imagetech Private Limited and 2 more | Managing Director | 03 May 2011 | 15 Years 6 Months | Current |
| Harkaran Dhingra Also directs: Neodx Biotech Labs Private Limited, Magnus Opto Systems India Private Limited, DSS Imagetech Private Limited and 3 more | Nominee Director | 21 Dec 2017 | 8 Years 10 Months | Current |
Peer comparison
DSS Takara Bio India Private Limited is compared with the 4 companies closest to it by revenue in the Biotechnology industry (Biotechnology), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bharat Immunologicals and Biologicals Corporation Limited | ₹79.49 Cr (FY 2022) | -9.0% | Uttar Pradesh, India | |||
| Indus Biotech Limited | ₹71.42 Cr (FY 2025) | 2.0% | Pune, Maharashtra, India | |||
| JC Biotech Private Limited | ₹60.12 Cr (FY 2025) | -4.0% | Hyderabad, Telangana, India | |||
| Biofusion Therapeutics Limited | ₹56.53 Cr (FY 2023) | 41.0% | Bengaluru, Karnataka, India | |||
| DSS Takara Bio India Private Limitedthis company | ₹39.54 Cr (FY 2023) | ₹3.38 Cr | 8.6% | -37.0% | New Delhi, Delhi, India |
To see the full peer comparison of DSS Takara Bio India Private Limited, buy the company report.
Auditor
DSS Takara Bio India Private Limited is audited by NAGPAL & NAGPAL ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NAGPAL & NAGPAL ASSOCIATES | FY 2023 | 012719N |
Shareholding
The shareholding of DSS Takara Bio India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of DSS Takara Bio India Private Limited, buy the company report.
Deals & funding
DSS Takara Bio India Private Limited has 2 deals on record (2 funding rounds), with disclosed funding of ₹10.95 Cr; the latest was in April 2013.
Total deals
2
Funding rounds
2
Disclosed funding
₹10.95 Cr
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2013 | Funding round | ₹6.5 Cr | Investors: Takara Bio Inc, DSS Imagetech Private Limited , Takara Bio USA Holdings Inc, an individual |
| Jun 2011 | Funding round | ₹4.45 Cr | Investors: Takara Bio Inc, DSS Imagetech Private Limited , Takara Bio USA Holdings Inc, an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
DSS Takara Bio India Private Limited has 5 court cases on record: 5 filed by DSS Takara Bio India. All cases are disposed.
Total cases
5
Filed by the company
5
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 0 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Criminal case | Filed by the company against Genome Diagnostics Private Limited | Disposed |
| District court, South East, Delhi | Civil suit | Filed by the company against M/S Bencos Research Solutions Private Limited and 2 others | Disposed |
| District court, South East, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Disposed |
| District court, South East, Delhi | Civil suit | Filed by the company against M/S 31 Molecular Solutions and Healthcare Services Private Limited and 2 others | Disposed |
| District court, South East, Delhi | Criminal case | Filed by the company against an individual | Disposed |
To see the full case history of DSS Takara Bio India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
DSS Takara Bio India Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2020, listing 1 overdue payment to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Parshuram Trade Links |
To see the full MSME payment records of DSS Takara Bio India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
DSS Takara Bio India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCD8286B1ZO | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of DSS Takara Bio India Private Limited, buy the company report.
Recent activity
DSS Takara Bio India Private Limited has 13 board changes on record since 2011: 5 appointments and 8 cessations. The latest: Hiroki Tomohisa was appointed as Nominee Director on 27 May 2025.
AGM
Dss Takara Bio India Private Limited last Annual general meeting of members was held on 27 May 2025 as per latest MCA records.
Appointed
Hiroki Tomohisa was appointed as Nominee Director.
Filing
Dss Takara Bio India Private Limited has filed its annual Financial statements for the year ended 31 Dec 2024 with Roc Delhi I.
Appointed
Tsuyoshi Miyamura was appointed as Nominee Director.
Ceased
Kazuki Yamamoto ceased to be Nominee Director.
Ceased
Tsuyoshi Miyamura ceased to be Nominee Director.
Ceased
Haruhisa Sawaragi ceased to be Nominee Director.
Appointed
Harkaran Dhingra was appointed as Nominee Director.
Ceased
Ushakar Nishikant Nag ceased to be Nominee Director.
Ceased
Hiroki Tomohisa ceased to be Nominee Director.
Appointed
Haruhisa Sawaragi was appointed as Nominee Director.
Ceased
Arvinder Singh Dhingra ceased to be Director.
4 earlier events are in the company report.
Frequently asked questions
DSS Takara Bio India is an active private limited company based in New Delhi, Delhi, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 03 May 2011 (15+ years old) and is registered under CIN U24232DL2011PTC218463.
DSS Takara Bio India has 4 current directors:
- Arvinder Singh Dhingra - Managing Director
- Haruhisa Sawaragi - Nominee Director
- Hiroki Tomohisa - Nominee Director
- Harkaran Dhingra - Nominee Director
The latest financial statements of DSS Takara Bio India on record with the MCA are for the year ended 31 December 2024. Its last annual general meeting was held on 27 May 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of DSS Takara Bio India is 07AADCD8286B1ZO, registered in Delhi.
The CIN (Corporate Identification Number) of DSS Takara Bio India is U24232DL2011PTC218463. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
DSS Takara Bio India has 5 court cases on record: 5 filed by the company.
DSS Takara Bio India was incorporated on 03 May 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
DSS Takara Bio India has 2 deals on record (2 funding rounds), with disclosed funding of ₹10.95 Cr; the latest was in April 2013.
The peers of DSS Takara Bio India by revenue are Bharat Immunologicals and Biologicals Corporation Limited, Indus Biotech Limited, JC Biotech Private Limited, Biofusion Therapeutics Limited, all in the Biotechnology industry (Biotechnology), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Hiroki Tomohisa was appointed as Nominee Director on 27 May 2025. Tsuyoshi Miyamura was appointed as Nominee Director on 28 May 2024. Kazuki Yamamoto ceased to be Nominee Director on 24 May 2022. DSS Takara Bio India has 13 board changes on record in total.
Yes, DSS Takara Bio India is registered as a small enterprise under Udyam registration (number: UDYAM-DL-09-0006158).
DSS Takara Bio India has 1 MSME Form 1 return on record for the period ending Mar 2020, listing 1 overdue payment to 1 micro and small supplier. The latest return was filed on 05 May 2020.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages